Eversept Partners, LP
- SEC CIK
- 0001697013
- Latest filing
- Aug 14, 2026
Holdings in Q3 2024
Holdings as of Sep 30, 2024, filed Nov 14, 2024. Long positions only; changes compare share counts with Q2 2024.
- Positions
- 65
- −7 vs. Q2 2024
- Portfolio value
- $1.30B
- −$3.09M (−0.2%) vs. Q2 2024
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| ACIUAC Immune SA | SHS | 99,313 | $375.4K | <0.1% | 00.0% | Unchanged | History |
| Affimed N VN01045207 | ORDINARY SHS NEW | 166,460 | $559.3K | <0.1% | 00.0% | Unchanged | – |
| STOKStoke Therapeutics, Inc. | COM | 52,006 | $639.2K | <0.1% | −9,271−15.1% | Reduced | History |
| JBIOJade Biosciences, Inc. | COM | 485,141 | $1.01M | 0.1% | +485,141 | New | History |
| ABSIAbsci Corp | COM | 272,869 | $1.04M | 0.1% | −52,640−16.2% | Reduced | History |
| LQDALiquidia Corp | COM NEW | 137,949 | $1.38M | 0.1% | −235,605−63.1% | Reduced | History |
| AUTLAutolus Therapeutics plc | SPON ADS | 406,558 | $1.48M | 0.1% | −204,344−33.4% | Reduced | History |
| ALECAlector, Inc. | COM | 332,756 | $1.55M | 0.1% | −208,983−38.6% | Reduced | History |
| NVRONevro Corp | COM | 313,780 | $1.75M | 0.1% | −185,615−37.2% | Reduced | History |
| AMRNAmarin Corp PLC | SPONS ADR NEW | 3,309,309 | $2.07M | 0.2% | −999,218−23.2% | Reduced | History |
| TRMLTourmaline Bio, Inc. | COM | 84,380 | $2.17M | 0.2% | −120,401−58.8% | Reduced | History |
| IFRXInflaRx N.V. | COM | 1,621,787 | $2.48M | 0.2% | +54,857+3.5% | Added | History |
| XOMAXOMA Royalty Corp | COM NEW | 94,289 | $2.50M | 0.2% | +2,382+2.6% | Added | History |
| MRVIMaravai Lifesciences Holdings, Inc. | COM CL A | 336,966 | $2.80M | 0.2% | +336,966 | New | History |
| IQVIQVIA Holdings Inc. | Stock | 13,138 | $3.11M | 0.2% | +960+7.9% | Added | History |
| MREOMereo BioPharma Group plc | SPON ADS | 777,890 | $3.20M | 0.2% | +281,719+56.8% | Added | History |
| ZBIOZenas BioPharma, Inc. | COM | 190,531 | $3.22M | 0.2% | +190,531 | New | History |
| ZLABZai Lab Ltd | ADR | 135,219 | $3.26M | 0.3% | +135,219 | New | History |
| PBYIPuma Biotechnology, Inc. | COM | 1,293,257 | $3.30M | 0.3% | −35,197−2.6% | Reduced | History |
| STAAStaar Surgical Co | COM PAR $0.01 | 91,199 | $3.39M | 0.3% | +91,199 | New | History |
| MRUSMerus N.V. | COM | 68,258 | $3.41M | 0.3% | +1,784+2.7% | Added | History |
| MOHMolina Healthcare, Inc. | COM | 10,588 | $3.65M | 0.3% | −7,689−42.1% | Reduced | History |
| KURAKura Oncology, Inc. | COM | 192,398 | $3.76M | 0.3% | +120,081+166.0% | Added | History |
| ICLRIcon PLC | COM | 13,668 | $3.93M | 0.3% | +1,026+8.1% | Added | History |
| BCRXBiocryst Pharmaceuticals Inc | COM | 535,405 | $4.07M | 0.3% | −617,168−53.5% | Reduced | History |
| AVTRAvantor, Inc. | COM | 168,369 | $4.36M | 0.3% | +42,975+34.3% | Added | History |
| KPTIKaryopharm Therapeutics Inc. | COM | 5,547,880 | $4.60M | 0.4% | +560,700+11.2% | Added | History |
| TSVT2seventy bio, Inc. | COMMON STOCK | 998,079 | $4.71M | 0.4% | −109,664−9.9% | Reduced | History |
| GOSSGossamer Bio, Inc. | COM | 4,978,458 | $4.91M | 0.4% | −505,690−9.2% | Reduced | History |
| FNAParagon 28, Inc. | COM | 749,213 | $5.00M | 0.4% | +749,213 | New | History |
| NAMSNewAmsterdam Pharma Co N.V. | ORDINARY SHARES | 307,357 | $5.10M | 0.4% | −22,533−6.8% | Reduced | History |
| BKDBrookdale Senior Living Inc. | COM | 861,268 | $5.85M | 0.4% | −685,574−44.3% | Reduced | History |
| STROSutro Biopharma, Inc. | COM | 1,841,989 | $6.37M | 0.5% | +102,860+5.9% | Added | History |
| ARQTArcutis Biotherapeutics, Inc. | COM | 693,263 | $6.45M | 0.5% | −144,584−17.3% | Reduced | History |
| BHVNBiohaven Ltd. | COM | 132,537 | $6.62M | 0.5% | +132,537 | New | History |
| EOLSEvolus, Inc. | COM | 453,061 | $7.34M | 0.6% | −121,401−21.1% | Reduced | History |
| ITCIIntra-Cellular Therapies, Inc. | COM | 124,491 | $9.11M | 0.7% | +124,491 | New | History |
| FTREFortrea Holdings Inc. | COMMON STOCK | 457,967 | $9.16M | 0.7% | +457,967 | New | History |
| ELVElevance Health, Inc. | Stock | 19,465 | $10.1M | 0.8% | +4,808+32.8% | Added | History |
| CNCCentene Corp | Stock | 134,959 | $10.2M | 0.8% | +19,139+16.5% | Added | History |
| DHRDanaher Corp | Stock | 38,429 | $10.7M | 0.8% | −2,426−5.9% | Reduced | History |
| HUMHumana Inc | Stock | 33,860 | $10.7M | 0.8% | −4,163−10.9% | Reduced | History |
| TVTXTravere Therapeutics, Inc. | COM | 869,913 | $12.2M | 0.9% | −221,252−20.3% | Reduced | History |
| BHCBausch Health Companies Inc. | Stock | 1,530,914 | $12.5M | 1.0% | +1,530,914 | New | History |
| MNKDMannkind Corp | COM NEW | 1,992,504 | $12.5M | 1.0% | −264,448−11.7% | Reduced | History |
| VRDNViridian Therapeutics, Inc. | COM | 691,232 | $15.7M | 1.2% | +123,745+21.8% | Added | History |
| IONSIonis Pharmaceuticals Inc | COM | 471,355 | $18.9M | 1.4% | +14,474+3.2% | Added | History |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 564,902 | $19.2M | 1.5% | −68,113−10.8% | Reduced | History |
| PTGXProtagonist Therapeutics, Inc | COM | 445,204 | $20.0M | 1.5% | −60,632−12.0% | Reduced | History |
| VTRSViatris Inc | Stock | 1,726,354 | $20.0M | 1.5% | +397,072+29.9% | Added | History |
| RGENRepligen Corp | COM | 163,593 | $24.3M | 1.9% | −30,698−15.8% | Reduced | History |
| HQYHealthequity, Inc. | COM | 319,078 | $26.1M | 2.0% | −94,453−22.8% | Reduced | History |
| ZIMVZimVie Inc. | Stock | 2,070,780 | $32.9M | 2.5% | +1,303,121+169.8% | Added | History |
| UTHRUnited Therapeutics Corp | COM | 130,949 | $46.9M | 3.6% | −104,402−44.4% | Reduced | History |
| HCAHCA Healthcare, Inc. | COM | 129,084 | $52.5M | 4.0% | −6,396−4.7% | Reduced | History |
| TECHBIO-TECHNE Corp | COM | 663,573 | $53.0M | 4.1% | +120,529+22.2% | Added | History |
| CYHCommunity Health Systems Inc | COM | 8,776,455 | $53.3M | 4.1% | +738,985+9.2% | Added | History |
| TEVATeva Pharmaceutical Industries Ltd | SPONSORED ADS | 3,234,638 | $58.3M | 4.5% | −1,485,822−31.5% | Reduced | History |
| INSPInspire Medical Systems, Inc. | COM | 276,270 | $58.3M | 4.5% | −256,741−48.2% | Reduced | History |
| RVTYRevvity, Inc. | COM | 469,692 | $60.0M | 4.6% | +18,110+4.0% | Added | History |
| SNDXSyndax Pharmaceuticals Inc | COM | 4,105,313 | $79.0M | 6.1% | +491,682+13.6% | Added | History |
| INSMINSMED Inc | COM PAR $.01 | 1,089,404 | $79.5M | 6.1% | −66,184−5.7% | Reduced | History |
| VERAVera Therapeutics, Inc. | CL A | 2,050,157 | $90.6M | 7.0% | +6,943+0.3% | Added | History |
| NTRANatera, Inc. | COM | 870,193 | $110.5M | 8.5% | −303,301−25.8% | Reduced | History |
| GSKGSK plc | ADR | 4,057,206 | $165.9M | 12.7% | +589,126+17.0% | Added | History |
Options (2)
Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.
| Security | Class | Puts | Calls |
|---|---|---|---|
| Invesco QQQ Trust Series I46090E103 | ETF | $121.8M | – |
| SPYSPDR S&P 500 ETF Trust | ETF | $34.4M | – |
Sold out since Q2 2024 (17)
Positions held at the end of Q2 2024 that are gone from this filing.
| Security | Class | Shares in Q2 2024 | Value in Q2 2024 | % of portfolio in Q2 2024 | History |
|---|---|---|---|---|---|
| NVONovo Nordisk A S | ADR | 146,956 | $21.0M | 1.6% | History |
| LLYEli Lilly & Co | Stock | 21,233 | $19.2M | 1.5% | History |
| ARGXArgenx SE | SPONSORED ADR | 34,593 | $14.9M | 1.1% | History |
| State Street SPDR S&P Biotech ETF78464A870 | ETF | 100,000 | $9.27M | 0.7% | – |
| VKTXViking Therapeutics, Inc. | COM | 138,489 | $7.34M | 0.6% | History |
| PCVXVaxcyte, Inc. | COM | 96,089 | $7.26M | 0.6% | History |
| CYTKCytokinetics Inc | COM NEW | 126,877 | $6.87M | 0.5% | History |
| OSCROscar Health, Inc. | CL A | 310,893 | $4.92M | 0.4% | History |
| CERECerevel Therapeutics Holdings, Inc. | COM | 110,010 | $4.50M | 0.3% | History |
| MYGNMyriad Genetics Inc | COM | 181,961 | $4.45M | 0.3% | History |
| MLTXMoonLake Immunotherapeutics | CLASS A ORD | 71,596 | $3.15M | 0.2% | History |
| GHGuardant Health, Inc. | COM | 99,377 | $2.87M | 0.2% | History |
| IMVTImmunovant, Inc. | COM | 92,909 | $2.45M | 0.2% | History |
| TERNTerns Pharmaceuticals, Inc. | COM | 286,266 | $1.95M | 0.1% | History |
| FULCFulcrum Therapeutics, Inc. | COM | 152,965 | $948.4K | 0.1% | History |
| GTHXG1 Therapeutics, Inc. | COM | 199,963 | $455.9K | <0.1% | History |
| MCRBSeres Therapeutics, Inc. | COM | 418,208 | $302.7K | <0.1% | History |